Search research articles
Contact Us
Filters
Showing results (361-370 of 451) with videos related to
Page
of 46
Sort By:
European Journal of Heart Failure
|
October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF
Adriaan A Voors, Beth A Davison, John R Teerlink, et al.
European Journal of Heart Failure
|
July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure
Iris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
Beth A Davison, Gad Cotter, Hengrui Sun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1982
Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V)
A G Jones, A Davison, M R LaTegola, et al.
JACC. Heart Failure
|
October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
Yuya Matsue, Iziah E Sama, Douwe Postmus, et al.
Circulation. Heart Failure
|
November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study
John G Cleland, Karen Chiswell, John R Teerlink, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 29, 2017
Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
European Journal of Heart Failure
|
September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
Heart Rhythm
|
April 26, 2016
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P Piccini, Edward L C Pritchett, Beth A Davison, et al.
Page
of 46
Search research articles
Search
Showing results (361-370 of 451) with videos related to
Sort By:
Page
of 46
European Journal of Heart Failure
|
October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF
Adriaan A Voors, Beth A Davison, John R Teerlink, et al.
European Journal of Heart Failure
|
July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure
Iris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
Beth A Davison, Gad Cotter, Hengrui Sun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1982
Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V)
A G Jones, A Davison, M R LaTegola, et al.
JACC. Heart Failure
|
October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
Yuya Matsue, Iziah E Sama, Douwe Postmus, et al.
Circulation. Heart Failure
|
November 28, 2013
Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study
John G Cleland, Karen Chiswell, John R Teerlink, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 29, 2017
Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
American Heart Journal
|
June 9, 2021
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A Davison, Christopher Edwards, et al.
European Journal of Heart Failure
|
September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
Heart Rhythm
|
April 26, 2016
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P Piccini, Edward L C Pritchett, Beth A Davison, et al.
Page
of 46